Health-related quality of life in diabetes: The associations of complications with EQ-5D scores

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Solli, Oddvar ^a   Stavem, Knut ^b,c   Kristiansen, IS ^a,d  

^a UNIVERSITY OF OSLO   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; LONG ACTING INSULIN; ORAL ANTIDIABETIC AGENT; SHORT ACTING INSULIN; UNCLASSIFIED DRUG;

ADULT; ANXIETY; ARTICLE; CEREBROVASCULAR ACCIDENT; COMPLICATION; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DIABETIC NEUROPATHY; EQ 5D SCORE; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; PATIENT CARE; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; HEALTH STATUS INDICATOR; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; STATISTICAL MODEL;

ADULT; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; NORWAY; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 77649127032     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-18     Document Type: Article

References (25)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053. 10.2337/diacare.27.5.1047, 15111519.
2. Grandy S, Fox K. EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Health and Quality of Life Outcomes 2008, 6:18. 10.1186/1477-7525-6-18, 2266905, 18304340.
3. Holmes J, McGill S, Kind P, Bottomley J, Gillam S, Murphy M. Health-related quality of life in type 2 diabetes (TARDIS-2). Value Health 2000, 3(Suppl 1):47-51. 10.1046/j.1524-4733.2000.36028.x, 16464209.
4. Koopmanschap M. Coping with Type II diabetes: the patient's perspective. Diabetologia 2002, 45:S18-S22.
5. Wexler D, Grant R, Wittenberg E, Bosch J, Cagliero E, Delahanty L, et al. Correlates of health-related quality of life in type 2 diabetes. Diabetologia 2006, 49:1489-1497. 10.1007/s00125-006-0249-9, 16752167.
6. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999, 8:79-91. 10.1023/A:1026485130100, 10457741.
7. Fitzgerald JT, Davis WK, Connell CM, Hess GE, Funnell MM, Hiss RG. Development and validation of the Diabetes Care Profile. Eval Health Prof 1996, 19:208-230. 10.1177/016327879601900205, 10186911.
8. Hirsch A, Bartholomae C, Volmer T. Dimensions of quality of life in people with non-insulin-dependent diabetes. Quality of Life Research 2000, 9:207-218. 10.1023/A:1008959810698, 10983484.
9. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483. 10.1097/00005650-199206000-00002, 1593914.
10. EuroQol Group EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. 10.1016/0168-8510(90)90421-9, 10109801, EuroQol Group.
11. Sintonen H. [Health-related quality of life measures]. Sairaanhoitaja 1993, 17-19.
12. Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001, 33:375-384. 10.3109/07853890109002092, 11491197.
13. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI(R)): concepts, measurement properties and applications. Health and Quality of Life Outcomes 2003, 1:54. 10.1186/1477-7525-1-54, 293474, 14613568.
14. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics 2002, 21:271-292. 10.1016/S0167-6296(01)00130-8, 11939242.
15. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res 1972, 7:118-133. 1067402, 5044699.
16. Klarman H, Francis JO, Rosenthal GDP. Cost Effectiveness Analysis Applied to the Treatment of Chronic Renal Disease. [Article]. Medical Care 1968, 6:48-54.
17. Glasziou P, Alexander J, Beller E, Clarke P, . the ADVANCE Collaborative Group Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health and Quality of Life Outcomes 2007, 5:21. 10.1186/1477-7525-5-21, 1950473, 17462100, the ADVANCE Collaborative Group.
18. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997, 35:1095-1108. 10.1097/00005650-199711000-00002, 9366889.
19. Speight J, Reaney MD, Barnard KD. Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes. Diabet Med 2009, 26:315-327. 10.1111/j.1464-5491.2009.02682.x, 19388959.
20. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group. Diabetes Care 1999, 22:1125-1136. 10.2337/diacare.22.7.1125, 10388978.
21. Matza LS, Boye KS, Yurgin N, Brewster-Jordan J, Mannix S, Shorr JM, et al. Utilities and disutilities for type 2 diabetes treatment-related attributes. Qual Life Res 2007, 16:1251-1265. 10.1007/s11136-007-9226-0, 17638121.
22. Dennett SL, Boye KS, Yurgin NR. The impact of body weight on patient utilities with or without type 2 diabetes: a review of the medical literature. Value Health 2008, 11:478-486. 10.1111/j.1524-4733.2007.00260.x, 18489671.
23. Burstrom K, Johannesson M, Diderichsen F. Swedish population health-related quality of life results using the EQ-5D. Qual Life Res 2001, 10:621-635. 10.1023/A:1013171831202, 11822795.
24. Norinder AGPK. Estimating Danish EuroQol tariffs using the Time Trade off (TTO) and Visula Analogue Scale (VAS) Methods. Proceedings of the 18th Plenary Meeting of the EuroQol Group 2002, 257-292. Roos P.
25. Nord E. EuroQol®: health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy 1991, 18:25-36. 10.1016/0168-8510(91)90141-J, 10112299.